Privacy Policy

This website uses our own cookies to collect information in order to improve our services, and to analyse users’ browsing habits. Your continued use of this website constitutes acceptance of the installation of these cookies. The user has the option of configuring their browser in order to prevent cookies from being installed on their hard drive, although they must keep in mind that doing so may cause difficulties in their use of the webpage.

Accept Accept Essentials Customize Reject Cookie policy

Breakthrough in cancer research

By Jerry Brownstein
19 Mar 2021 100 Share
Researchers at Cardiff University (UK) have discovered a new type of killer immune cell (T-cell) that has the potential to be an effective therapy against numerous types of cancer. T-cell therapies are a growing field in cancer treatment. The way it works is that immune cells are removed to be modified, and then they are returned to the patient's blood to seek and destroy cancer cells. However, up to now this process could only target a limited number of cancers, and was not successful against solid tumours - which make up the majority of cancers. These newly discovered T-cells are equipped with a T-cell receptor (TCR), which recognises and kills most human cancer types while ignoring healthy cells.

According to professor Andrew Sewell who headed the study, “This raises the possibility of a 'one-size-fits-all' cancer treatment; a single type of T-cell capable of destroying many different types of cancers.” In the lab, T-cells equipped with the new TCR were shown to kill lung, skin, blood, colon, breast, bone, prostate, ovarian, kidney and cervical cancer cells, while ignoring healthy cells. “If this transformative new finding holds up, it will lay the foundation for a universal T-cell medicine, and a great step forward for cancer immunotherapy.”

Ibicasa logo

© Copyright 2026

Ibiza's & Formentera's Real Estate Portal